HLCS Insider Trading Activity and SEC Form 4 Filings
HLCS insider trading summary
No open-market insider purchases or sales of Helicos Biosciences Corp (HLCS) have been reported on SEC Form 4 in the past 12 months.
Latest HLCS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 18, 2009 | William J Phd Link | 10% Owner | Buy | $625K (242,931 @ $2.57) |
| Sep 18, 2009 | Rebecca B Robertson | 10% Owner | Buy | $625K (242,931 @ $2.57) |
| Sep 18, 2009 | Bradley J PhD Bolzon | 10% Owner | Buy | $625K (242,931 @ $2.57) |
| Sep 18, 2009 | Versant Venture Capital II, LP | 10% Owner | Buy | $625K (242,931 @ $2.57) |
| Sep 18, 2009 | Samuel D Colella | 10% Owner | Buy | $625K (242,931 @ $2.57) |
| Sep 18, 2009 | Ross A Md Jaffe | 10% Owner | Buy | $625K (242,931 @ $2.57) |
| Sep 18, 2009 | Barbara N Lubash | 10% Owner | Buy | $625K (242,931 @ $2.57) |
| Sep 18, 2009 | Charles M Warden | 10% Owner | Buy | $625K (242,931 @ $2.57) |
| Sep 18, 2009 | Donald B Milder | 10% Owner | Buy | $625K (242,931 @ $2.57) |
| Sep 18, 2009 | Camille D Samuels | 10% Owner | Buy | $625K (242,931 @ $2.57) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.